Patient-Led Research Collaborative, Washington, DC, USA.
Patient-Led Research Collaborative, Washington, DC, USA; University of California, San Francisco, San Francisco, CA, USA.
Cell. 2024 Oct 3;187(20):5490-5496. doi: 10.1016/j.cell.2024.09.011.
Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.
长新冠是一种慢性且常常致残的疾病,具有长期影响。尽管在长新冠的临床特征描述方面已经取得了进展,但目前尚无获批的治疗方法,而患者与研究人员之间的脱节有可能阻碍未来的进展。将患者纳入长新冠研究的积极合作者可以弥合这一差距,并加速治疗和治愈方法的研究进展。